Stockscreener 앱 받기
2.95
0.67%
-0.02
시간 외 거래:
2.95
전일 마감가:
$2.97
열려 있는:
$3
하루 거래량:
22,983
Relative Volume:
0.52
시가총액:
$10.03M
수익:
$125.00K
순이익/손실:
$-14.33M
주가수익비율:
-0.4237
EPS:
-6.9622
순현금흐름:
$-14.95M
1주 성능:
-6.05%
1개월 성능:
-9.51%
6개월 성능:
-40.76%
1년 성능:
-75.61%
1일 변동 폭
$2.90
$3.00
1주일 범위
$2.86
$3.2375
52주 변동 폭
$2.86
$41.22
Imunon Inc Stock (IMNN) Company Profile
명칭
Imunon Inc
전화
(609) 896-9100
주소
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
2.95 | 10.10M | 125.00K | -14.33M | -14.95M | -6.9622 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Imunon Inc 주식(IMNN)의 최신 뉴스
S P Trends: What is the next catalyst for Imunon Inc2026 Weekly Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Dividend Watch: Will Imunon Inc outperform tech stocksQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Imunon Q2 2025 Earnings Preview - MSN
Imunon declares $0.15 dividend - MSN
Signal Recap: Will Imunon Inc outperform tech stocksGold Moves & Low Risk Entry Point Guides - baoquankhu1.vn
Market Overview: Is Imunon Inc a defensive stock2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
IMNN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
IMNN SEC FilingsImunon Inc 10-K, 10-Q, 8-K Forms - Stock Titan
IMNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Imunon Inc expected to post a loss of $1.17 a shareEarnings Preview - TradingView
What risks investors should watch in Imunon Inc. stockWeekly Profit Report & Risk Controlled Swing Alerts - mfd.ru
Can Imunon Inc continue delivering strong returnsJuly 2025 Chart Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Armistice Capital takes 9.99% stake in Imunon (IMNN) - Stock Titan
Will Imunon Inc. outperform small cap indexesWeekly Risk Report & Free Community Supported Trade Ideas - mfd.ru
Will Imunon Inc. outperform tech stocksQuarterly Trade Report & Technical Entry and Exit Alerts - mfd.ru
Should I invest in Imunon Inc. before earningsIPO Watch & Consistent Profit Trade Alerts - mfd.ru
FY2025 Earnings Estimate for Imunon Issued By HC Wainwright - Defense World
Imunon stock price target raised to $25 from $14 at H.C. Wainwright By Investing.com - Investing.com South Africa
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Oncolytics Biotech (ONCY) and Imunon (IMNN) - The Globe and Mail
IMNN: Streamlining Operations to Focus on OVATION 3 - Smartkarma
Rate Hike: Will Imunon Inc outperform its industry peersJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Imunon stock price target raised to $25 from $14 at H.C. Wainwright - Investing.com Australia
Imunon, Inc. Announces Retirement of Executive Vice President and Chief Scientific Officer Khursheed Anwer, Effective February 20, 2026 - marketscreener.com
Imunon sharpens focus on its promising pivotal Phase 3 ovarian cancer study - marketscreener.com
IMUNON rises on plan to shift resources to ovarian cancer therapy - TradingView
Imunon stock rises following strategic restructuring to focus on Phase 3 trial - Investing.com Nigeria
Imunon stock rises following strategic restructuring to focus on Phase 3 trial By Investing.com - Investing.com South Africa
Imunon announces orderly retirement of chief scientific officer - TipRanks
IMUNON, Inc. Announces Strategic Restructuring and Retirement of Chief Scientific Officer to Advance Phase 3 Clinical Trial - Quiver Quantitative
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY - One News Page
Resistance Check: Is MLTX stock a buy or sellGold Moves & Safe Entry Momentum Tips - baoquankhu1.vn
Stock Analysis: Can Imunon Inc sustain earnings growthTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
Imunon CEO says ‘poised for key milestones’ as company enters 2026 - MSN
Pullback Watch: Can Imunon Inc continue delivering strong returnsQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Aug Mood: What is Franklin BSP Realty Trust Incs debt to equity ratioPortfolio Gains Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Is Imunon Inc. stock a good pick for beginnersQuarterly Earnings Summary & Verified Momentum Watchlists - bollywoodhelpline.com
IPO Launch: Why Imunon Inc stock is recommended by analystsJuly 2025 Volume & AI Driven Stock Price Forecasts - Bộ Nội Vụ
Aug Weekly: What is Five Below Incs revenue forecastPortfolio Performance Summary & Low Risk High Reward Ideas - baoquankhu1.vn
Head to Head Review: Allogene Therapeutics (NASDAQ:ALLO) and Imunon (NASDAQ:IMNN) - Defense World
Market Review: Will Imunon Inc stock deliver shareholder valueWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - Bộ Nội Vụ
Imunon, Inc. (NASDAQ:IMNN) Receives $232.50 Average Price Target from Analysts - Defense World
Can Imunon Inc. stock maintain growth trajectoryMarket Movement Recap & Daily Entry Point Trade Alerts - Улправда
How Imunon Inc. stock performs in stagflationChart Signals & Expert Approved Momentum Trade Ideas - Улправда
Will Imunon Inc. stock deliver shareholder valueMarket Rally & Risk Controlled Stock Pick Alerts - Улправда
Can Imunon Inc. stock attract ESG capital inflowsQuarterly Trade Summary & High Conviction Buy Zone Picks - Улправда
Imunon Announces CFO Transition and Reappointment of Jeffrey Church - The Globe and Mail
Imunon IncInterim CFO Kimberly Graper To Resign January 14, 2026SEC Filing - TradingView — Track All Markets
Imunon, Inc. Announces CFO Transition - TradingView — Track All Markets
Imunon, Inc. Announces Executive Changes, Effective January 14, 2026 - marketscreener.com
Brookline Capital lowers Imunon stock price target to $16 on offering dilution By Investing.com - Investing.com Nigeria
Brookline Capital lowers Imunon stock price target to $16 on offering dilution - Investing.com Nigeria
Imunon Inc (IMNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):